Literature DB >> 15650179

Elimination of retroviral infectivity by N-ethylmaleimide with preservation of functional envelope glycoproteins.

David R Morcock1, James A Thomas, Tracy D Gagliardi, Robert J Gorelick, J David Roser, Elena N Chertova, Julian W Bess, David E Ott, Quentin J Sattentau, Ines Frank, Melissa Pope, Jeffrey D Lifson, Louis E Henderson, Bruce J Crise.   

Abstract

The zinc finger motifs in retroviral nucleocapsid (NC) proteins are essential for viral replication. Disruption of these Cys-X2-Cys-X4-His-X4-Cys zinc-binding structures eliminates infectivity. To determine if N-ethylmaleimide (NEM) can inactivate human immunodeficiency virus type 1 (HIV-1) or simian immunodeficiency virus (SIV) preparations by alkylating cysteines of NC zinc fingers, we treated infectious virus with NEM and evaluated inactivation of infectivity in cell-based assays. Inactivation was rapid and proportional to the NEM concentration. NEM treatment of HIV-1 or SIV resulted in extensive covalent modification of NC and other internal virion proteins. In contrast, viral envelope glycoproteins, in which the cysteines are disulfide bonded, remained intact and functional, as assayed by high-performance liquid chromatography, fusion-from-without analyses, and dendritic cell capture. Quantitative PCR assays for reverse transcription intermediates showed that NEM and 2,2'-dipyridyl disulfide (aldrithiol-2), a reagent which inactivates retroviruses through oxidation of cysteines in internal virion proteins such as NC, blocked HIV-1 reverse transcription prior to the formation of minus-strand strong-stop products. However, the reverse transcriptase from NEM-treated virions remained active in exogenous template assays, consistent with a role for NC in reverse transcription. Since disruption of NC zinc finger structures by NEM blocks early postentry steps in the retroviral infection cycle, virus preparations with modified NC proteins may be useful as vaccine immunogens and probes of the role of NC in viral replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650179      PMCID: PMC544125          DOI: 10.1128/JVI.79.3.1533-1542.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  63 in total

1.  Characterization of clones of HIV-1 infected HuT 78 cells defective in gag gene processing and of SIV clones producing large amounts of envelope glycoprotein.

Authors:  R E Benveniste; R W Hill; L J Eron; U M Csaikl; W B Knott; L E Henderson; R C Sowder; K Nagashima; M A Gonda
Journal:  J Med Primatol       Date:  1990       Impact factor: 0.667

2.  Extended x-ray absorption fine structure studies of a retrovirus: equine infectious anemia virus cysteine arrays are coordinated to zinc.

Authors:  M R Chance; I Sagi; M D Wirt; S M Frisbie; E Scheuring; E Chen; J W Bess; L E Henderson; L O Arthur; T L South
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

Authors:  J Kimpton; M Emerman
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

4.  Production and of monoclonal antibodies to simian immunodeficiency virus envelope glycoproteins.

Authors:  K A Kent; L Gritz; G Stallard; M P Cranage; C Collignon; C Thiriart; T Corcoran; P Silvera; E J Stott
Journal:  AIDS       Date:  1991-07       Impact factor: 4.177

5.  Partial reverse transcripts in virions from human immunodeficiency and murine leukemia viruses.

Authors:  D Trono
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

6.  Tightly bound zinc in human immunodeficiency virus type 1, human T-cell leukemia virus type I, and other retroviruses.

Authors:  J W Bess; P J Powell; H J Issaq; L J Schumack; M K Grimes; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

7.  Nucleocapsid zinc fingers detected in retroviruses: EXAFS studies of intact viruses and the solution-state structure of the nucleocapsid protein from HIV-1.

Authors:  M F Summers; L E Henderson; M R Chance; J W Bess; T L South; P R Blake; I Sagi; G Perez-Alvarado; R C Sowder; D R Hare
Journal:  Protein Sci       Date:  1992-05       Impact factor: 6.725

8.  Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.

Authors:  W G Rice; C A Schaeffer; B Harten; F Villinger; T L South; M F Summers; L E Henderson; J W Bess; L O Arthur; J S McDougal
Journal:  Nature       Date:  1993-02-04       Impact factor: 49.962

9.  The two zinc fingers in the human immunodeficiency virus type 1 nucleocapsid protein are not functionally equivalent.

Authors:  R J Gorelick; D J Chabot; A Rein; L E Henderson; L O Arthur
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

10.  Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA.

Authors:  James S Buckman; William J Bosche; Robert J Gorelick
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  21 in total

1.  Failure of HIV-exposed CD4+ T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions.

Authors:  Rui Zhang; Jeffrey D Lifson; Claire Chougnet
Journal:  Blood       Date:  2005-11-03       Impact factor: 22.113

Review 2.  Nucleocapsid protein function in early infection processes.

Authors:  James A Thomas; Robert J Gorelick
Journal:  Virus Res       Date:  2008-02-14       Impact factor: 3.303

3.  Flow Virometry to Analyze Antigenic Spectra of Virions and Extracellular Vesicles.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Sonia Zicari; Murad Vagida; Jean-Charles Grivel; Leonid Margolis
Journal:  J Vis Exp       Date:  2017-01-25       Impact factor: 1.355

4.  A fusion inhibitor prevents spread of immunodeficiency viruses, but not activation of virus-specific T cells, by dendritic cells.

Authors:  I Frank; H Stössel; A Gettie; S G Turville; J W Bess; J D Lifson; I Sivin; N Romani; M Robbiani
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

Review 5.  HIV type 1 Gag as a target for antiviral therapy.

Authors:  Abdul A Waheed; Eric O Freed
Journal:  AIDS Res Hum Retroviruses       Date:  2011-09-21       Impact factor: 2.205

6.  Flow virometry analysis of envelope glycoprotein conformations on individual HIV virions.

Authors:  Anush Arakelyan; Wendy Fitzgerald; Deborah F King; Paul Rogers; Hannah M Cheeseman; Jean-Charles Grivel; Robin J Shattock; Leonid Margolis
Journal:  Sci Rep       Date:  2017-04-19       Impact factor: 4.379

7.  Fusion Stage of HIV-1 Entry Depends on Virus-Induced Cell Surface Exposure of Phosphatidylserine.

Authors:  Elena Zaitseva; Eugene Zaitsev; Kamran Melikov; Anush Arakelyan; Mariana Marin; Rafael Villasmil; Leonid B Margolis; Gregory B Melikyan; Leonid V Chernomordik
Journal:  Cell Host Microbe       Date:  2017-07-12       Impact factor: 21.023

Review 8.  Simian immunodeficiency virus interactions with macaque dendritic cells.

Authors:  Natalia Teleshova; Nina Derby; Elena Martinelli; Pavel Pugach; Giulia Calenda; Melissa Robbiani
Journal:  Adv Exp Med Biol       Date:  2013       Impact factor: 2.622

9.  Antigenic composition of single nano-sized extracellular blood vesicles.

Authors:  Anush Arakelyan; Oxana Ivanova; Elena Vasilieva; Jean-Charles Grivel; Leonid Margolis
Journal:  Nanomedicine       Date:  2014-12-03       Impact factor: 5.307

10.  Movements of HIV-virions in human cervical mucus.

Authors:  Hacène Boukari; Beda Brichacek; Pamela Stratton; Sheila F Mahoney; Jeffrey D Lifson; Leonid Margolis; Ralph Nossal
Journal:  Biomacromolecules       Date:  2009-09-14       Impact factor: 6.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.